Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells

Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells

US Patent 12161688 · Granted Dec 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Depot systems comprising glatiramer acetate2025
Depot systems comprising glatiramer acetate2025
Method for suppressing or alleviating primary or secondary progressive multiple 2025
Method for suppressing or alleviating primary or secondary progressive multiple 2025
Depot systems comprising cariprazine or salts thereof2025
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof2025
Process for preparing microparticles containing glatiramer acetate2024
Process for preparing microparticles containing glatiramer acetate2024
Depot systems comprising Cariprazine or salts thereof2024
Semaglutide depot systems and use thereof2024
Semaglutide depot systems and use thereof2024
Treatment of multiple sclerosis with adipose-derived stem cells2022